Our results showed that DG treatment markedly ameliorated oxidative stress in MGN rats, evidenced by decreased MDA and NO contents and enhanced activities of antioxidant enzymes, such as SOD, CAT, GSH and GPx. The gene discussed is SOD1; the disease is idiopathic membranous glomerulonephritis.